发明名称 |
USE OF LAQUINIMOD FOR REDUCING FATIGUE, IMPROVING FUNCTIONAL STATUS, AND IMPROVING QUALITY OF LIFE IN MULTIPLE SCLEROSIS PATIENTS |
摘要 |
<p>The subject invention provides methods for reducing or inhibiting progression of the level of fatigue in a multiple sclerosis human patient, for improving or inhibiting deterioration of the functional status of a multiple sclerosis human patient, and for improving or inhibiting deterioration of the general health of a multiple sclerosis human patient, comprising orally administering to the human patient laquinimod or a pharmaceutically acceptable salt thereof. The subject invention also provides a method for providing neuroprotection to a human subject, the method comprising orally administering to the human subject laquinimod or a pharmaceutically acceptable salt thereof.</p> |
申请公布号 |
WO2012078591(A8) |
申请公布日期 |
2012.08.02 |
申请号 |
WO2011US63460 |
申请日期 |
2011.12.06 |
申请人 |
TEVA PHARMACEUTICAL INDUSTRIES LTD.;TEVA PHARMACEUTICALS USA, INC.;TARCIC, NORA;BAR-ZOHAR, DAN;KOFLER, DINA |
发明人 |
TARCIC, NORA;BAR-ZOHAR, DAN;KOFLER, DINA |
分类号 |
A61K31/47 |
主分类号 |
A61K31/47 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|